Investigation into drug resistance to cisplatin in cancer stem cell-enriched population in non-small cell lung cancer
Understanding drug resistance in cancer is of importance in treatment. Cancer stem cells are main factor for drug resistance. Therefore, the possible gene/gene interactions/proteins were explored in our study using a cancer stem cell-enriched population (H1299/S) derived from a parental non-small ce...
Saved in:
| Main Authors: | Dere Egemen, Akgün Oğuzhan, Aztopal Nazlıhan, Ulukaya Engin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-01-01
|
| Series: | Türk Biyokimya Dergisi |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/tjb-2024-0181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECT OF CHEMOTHERAPY WITH DOCETAXEL / CISPLATIN ON GRANULOCYTIC HEMOPOIESIS IN PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA
by: V. E. Goldberg, et al.
Published: (2016-11-01) -
β-Sitosterol Synergizes Cisplatin's Anti-Lung Cancer Activity: A Cell Line Study
by: Wisam Selman, et al.
Published: (2025-06-01) -
Ganoderic acid a potentiates cisplatin’s cytotoxicity on gallbladder cancer cells by promoting DNA damage and inhibiting cell stemness
by: Gan Zhang, et al.
Published: (2025-04-01) -
Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01) -
Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis
by: Zhuoying Yang, et al.
Published: (2024-10-01)